Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option. The Alliance for Clinical Trials in Oncology has announced positive results from the Phase III AMBASSADOR ...
Jan 26, 2024
0
0
Imaging the tumors of patients with advanced melanoma receiving pembrolizumab (Keytruda) after only one week—rather than the standard of around three months—identified metabolic changes that corresponded with treatment ...
Jan 24, 2024
0
0
Researchers at the Alliance of Bioversity International and CIAT and their collaborators have been working on how to harness the power of the estimated 549 million Wi-Fi hotspots worldwide, resulting in a project that used ...
Jan 16, 2024
0
0
Many people consider hookah smoking to be less dangerous than smoking regular cigarettes. Yet hookah smoke is known to contain carcinogens, heavy metals, and other compounds that cause inflammation and oxidative stress that ...
Jan 16, 2024
0
0
A new study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center shows that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy ...
Jan 11, 2024
0
0
Sleep might not be at the top of the list when you think about ways to boost your athletic performance. But it's just as important as your training program, nutrition and hydration.
Jan 10, 2024
0
1
For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benefit, according to a study published online ...
Dec 21, 2023
0
0
For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, ...
Dec 20, 2023
0
1
Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer. Which patients will benefit the most, however, remains unclear; current biomarkers ...
Dec 14, 2023
0
0
For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone induction and consolidation therapy and with ...
Dec 13, 2023
0
8
